{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:53Z","timestamp":1790808233175,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jvs.2016.03.429","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T18:40:09Z","timestamp":1463596809000},"page":"1009-1017.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization"],"prefix":"10.1016","volume":"64","author":[{"given":"Birgitta","family":"Sigvant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Kragsterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Falkenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Hasvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saga","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Thuresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Nordanstig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2016.03.429_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2016.03.429_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jvs.2007.02.004","article-title":"A\u00a0population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences","volume":"45","author":"Sigvant","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/HJR.0b013e3283361ce6","article-title":"Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study","volume":"17","author":"Achterberg","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jvs.2016.03.429_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.115.306403","article-title":"A\u00a0compendium on peripheral arterial disease","volume":"116","author":"Cooke","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2016.03.429_bib5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur J\u00a0Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: national health and Nutrition Examination study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2016.03.429_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/clc.22217","article-title":"Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry","volume":"36","author":"Rodriguez","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jvs.2016.03.429_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/HJR.0b013e32831c1383","article-title":"Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease","volume":"16","author":"Sigvant","year":"2009","journal-title":"Eur J\u00a0Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jvs.2016.03.429_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/152660280701400520","article-title":"TASC II section F on revascularization in PAD","volume":"14","author":"Norgren","year":"2007","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2016.03.429_bib10","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.jacc.2011.08.023","volume":"58","author":"Rooke","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2016.03.429_bib11","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2016.03.429_bib12","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2016.03.429_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2016.03.429_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jvs.2005.11.002","article-title":"Trends, complications, and mortality in peripheral vascular surgery","volume":"43","author":"Nowygrod","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib15","unstructured":"Swedvasc. The Swedish National Registry for Vascular Surgery. Available at: www.ucr.uu.se\/swedvasc. Accessed September 15, 2014."},{"key":"10.1016\/j.jvs.2016.03.429_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejvs.2007.11.007","article-title":"Twenty years with the Swedvasc registry","volume":"35","author":"Bjorck","year":"2008","journal-title":"Eur J\u00a0Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ejvs.2008.08.017","article-title":"External validation of the Swedvasc registry: a first-time individual cross-matching with the unique personal identity number","volume":"36","author":"Troeng","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ejvs.2015.07.021","article-title":"International Vascunet validation of the Swedvasc registry","volume":"50","author":"Venermo","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jvs.2016.03.429_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000345953","article-title":"Refinement of Swedish administrative registers to monitor stroke events on the national level","volume":"40","author":"Koster","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jvs.2016.03.429_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jvs.2016.03.429_bib22","series-title":"R: a language and environment for statistical computing","year":"2015"},{"key":"10.1016\/j.jvs.2016.03.429_bib23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jvs.2015.03.066","article-title":"Association between gender and outcomes of lower extremity peripheral vascular interventions","volume":"62","author":"Ferranti","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1067\/mva.2002.120043","article-title":"Sex-related differences in outcome after vascular interventions for lower limb ischemia","volume":"35","author":"Hultgren","year":"2002","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2016.03.429_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2261-14-9","article-title":"Continuing decrease in coronary heart disease mortality in Sweden","volume":"14","author":"Berg","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jvs.2016.03.429_bib26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease","volume":"47","author":"Feringa","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 63","key":"10.1016\/j.jvs.2016.03.429_bib27","first-page":"2","article-title":"Annual report SWEDEHEART 2012","volume":"48","year":"2014","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.jvs.2016.03.429_bib28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery\u00a0disease: a meta-analysis of randomized trials","volume":"301","author":"Berger","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2016.03.429_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.thromres.2005.03.011","article-title":"Relation between platelet microaggregates and ankle brachial index in patients with peripheral arterial disease","volume":"117","author":"Kudoh","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2016.03.429_bib30","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2005.10.039","article-title":"Adiponectin and inflammatory markers in peripheral arterial occlusive disease","volume":"188","author":"Iwashima","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2016.03.429_bib31","doi-asserted-by":"crossref","first-page":"14477","DOI":"10.3390\/ijms160714477","article-title":"Do the effects of secondary prevention of cardiovascular events in PAD patients differ from other atherosclerotic disease?","volume":"16","author":"Poredos","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jvs.2016.03.429_bib32","doi-asserted-by":"crossref","first-page":"h5349","DOI":"10.1136\/bmj.h5349","article-title":"Beta blockers are associated with increased risk of cardiovascular events after surgery","volume":"351","author":"Wise","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2016.03.429_bib33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/me.2004-0536","article-title":"Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II","volume":"20","author":"Hunyady","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jvs.2016.03.429_bib34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/00129784-200101050-00008","article-title":"Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications","volume":"1","author":"Asmar","year":"2001","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jvs.2016.03.429_bib35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2016.03.429_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2016.03.429_bib37","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2016.03.429_bib38","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0002-9149(02)02869-2","article-title":"Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication","volume":"90","author":"Thompson","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2016.03.429_bib39","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1046\/j.1532-5415.2002.50604.x","article-title":"Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials","volume":"50","author":"Regensteiner","year":"2002","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jvs.2016.03.429_bib40","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/bjs.8895","article-title":"Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication","volume":"99","author":"Stevens","year":"2012","journal-title":"Br J\u00a0Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152141630012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074152141630012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T19:54:12Z","timestamp":1536695652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074152141630012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S074152141630012X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2016.03.429","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726374501.793521272","asserted-by":"object"}]},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2016.03.429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}